Table 5.
Core biopsy (n = 95) | |||||||
First | Second | Third | Fourth | Fifth | Sixth | Surgical specimen (n = 95) | |
Malignancy found | 74 | 89 | 92 | 94 | 94 | 94 | 95 |
Tumor size | |||||||
TIS | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
T1 | 3 | 7 | 11 | 13 | 15 | 16 | 22 |
T2 | 15 | 18 | 29 | 30 | 35 | 36 | 59 |
T3 | 2 | 5 | 5 | 5 | 5 | 5 | 10 |
T4 | 1 | 2 | 2 | 2 | 2 | 2 | 3 |
Pathological type | 62 | 84 | 89 | 91 | 91 | 91 | 95 |
ER | 70 | 85 | 90 | 92 | 93 | 93 | 95 |
PR | 62 | 78 | 83 | 86 | 86 | 87 | 95 |
Her2 | 43 | 53 | 60 | 70 | 76 | 78 | 95 |
Grade | 60 | 74 | 77 | 79 | 80 | 80 | 95 |
Overall concordance | 24 | 34 | 44 | 52 | 56 | 59 | 95 |
CNB = core needle biopsy, ER = estrogen receptor, HER2 = human epidermal growth factor receptor-2, PR = progesterone receptor.